MansprostIV: Veil Preserving HoLEP vs. Stanadard HoLEP

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT03494049
Collaborator
(none)
180
1
2
67.7
2.7

Study Details

Study Description

Brief Summary

Postoperative transient stress urine leakage following Holmium laser enucleation of the prostate is one of the problems that frustrate both surgeon and patients

Standard HoLEP might be associated with some stretch of the sphincter and de-epithelization of the sphincter area anteriorly.

In Veil preserving HoLEP, early separation of the adenoma from the sphincter ring minimizes sphincter stretch. Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

Our hypothesis is that by this technique the early postoperative transient urine leak would be minimized and duration of leakage if anny would be shortened.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Veil sparring HoLEP
  • Procedure: Standard HoLEP
N/A

Detailed Description

Postoperative transient stress urine leakage following Holmium laser enucleation of the prostate is one of the problems that frustrate both surgeon and patients.

Many reports addressed different variables for the cause of post HoLEP urine leakage. Looking for a procedure done by a single surgeon who had tremendous experience of this procedure may enable investigators to identify precisely technical points of interest that may affect post HoLEP stress urine incontinence.

Standard HoLEP might be associated with some stretch of the sphincter and de-epithelization of the sphincter area anteriorly.

In Veil preserving HoLEP, early separation of the adenoma from the sphincter ring minimizes sphincter stretch. Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

Investigators' hypothesis is that by this technique the early postoperative transient urine leak would be minimized and duration of leakage if any would be shortened.

Study Design

Study Type:
Interventional
Actual Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Veil-preserving Versus Standard Holmium Laser Enucleation of the Prostate: Randomized Clinical Trial
Actual Study Start Date :
Apr 22, 2016
Actual Primary Completion Date :
Dec 8, 2020
Actual Study Completion Date :
Dec 12, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Veil sparring HoLEP

Early mucosal incision lateral to the Veru followed by early separation of the adenoma from the sphincter ring after identification of the plane of enucleation, this minimizes sphincter stretch. Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.

Procedure: Veil sparring HoLEP
Early mucosal incision; lateral to the Veru and proximal to the apical bulge of the adenoma, followed by early separation of the adenoma from the sphincter ring after identification of the plane of enucleation, this minimizes sphincter stretch. Furthermore, more proximal incision of the 12 O'clock mucosal strip sparring a veil of mucosa covering the sphincter ring.
Other Names:
  • early apical separation
  • Active Comparator: Standard HoLEP

    Standard HoLEP TECHNIQUE as described by Elhilali et al 2010

    Procedure: Standard HoLEP
    Holmium laser enucleation of the prostate in the standard approach described by Elhilali et al 2010

    Outcome Measures

    Primary Outcome Measures

    1. urine incontinence [1 month postoperative]

      one hour pad test for post prostatectomy incontinence, scale from 0 to 4, the higher the more incontinence

    Secondary Outcome Measures

    1. international prostate symptom score [1 year]

      Symptoms core assessment, score from 0 to 35, the higher the worse the urinary symptoms

    2. urine flow rate [1 year]

      rate of urine flow per unit time, how many milliliters of urine passed per second, above 15ml/second is normal

    3. urine incontinence [4 months postoperative]

      one hour pad test for post prostatectomy incontinence, scale from 0 to 4, the higher the more incontinence

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years and Older
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patients' age ≥50 years

    2. ASA (American society of anesthesiologists) score ≤3.

    3. TRUS estimated weight ≥40 grams.

    Exclusion criteria:
    Patients who have any of the following were excluded:
    1. Patient with neurological disorder which might affect bladder function as cerebrovascular stroke or Parkinson disease.

    2. Active urinary tract infection.

    3. Presence of bladder cancer (within the last 2 years).

    4. Prostate cancer patients.

    5. Patients with bleeding tendency, ongoing anticoagulants or antiplatelet medications

    6. Previous prostate surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Urology and nephrology center Mansoura DK Egypt 35516

    Sponsors and Collaborators

    • Mansoura University

    Investigators

    • Principal Investigator: Ahmed Elshal, Mansoura University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ahmed Elshal, Principal Investigator, Mansoura University
    ClinicalTrials.gov Identifier:
    NCT03494049
    Other Study ID Numbers:
    • Mans 1.2017
    First Posted:
    Apr 11, 2018
    Last Update Posted:
    Jul 19, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Jul 19, 2022